Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan Effects on Emphysema Progression
NCT02696564Phase 4Completed
- Sponsor
- Johns Hopkins Center for Clinical Trials and Evidence Synthesis
- Start
- May 2017
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in emphysema and chronic obstructive pulmonary disease (COPD) comparing Losartan with Placebo (2 arms). Primary endpoint: Change in Mean pct950 at 48 weeks. Started May 2017; status: completed.
02
Drugs
losartan
03
Conditions
emphysemachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02696564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02696564.